speb/financial-data huggingface dataset:
OCUL balance_sheet (annual, 2023-12-31) — Construction In Progress: 281000.00
OCUL income_statement (annual, 2023-12-31) — Cost Of Revenue: 5281000.00
OCUL balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 28666000.00
OCUL balance_sheet (annual, 2023-12-31) — Current Assets: 232235000.00
OCUL balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1586000.00
OCUL balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1586000.00
OCUL balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 255000.00
OCUL balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 255000.00
OCUL balance_sheet (annual, 2023-12-31) — Current Liabilities: 34896000.00
OCUL cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2983000.00
OCUL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2983000.00
OCUL balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 29987000.00
OCUL income_statement (annual, 2023-12-31) — Diluted Average Shares: 85596594.00
OCUL income_statement (annual, 2023-12-31) — Diluted EPS: -1.02
OCUL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -86969000.00
OCUL income_statement (annual, 2023-12-31) — EBIT: -69398000.00
OCUL income_statement (annual, 2023-12-31) — EBITDA: -66415000.00
OCUL cash_flow (annual, 2023-12-31) — End Cash Position: 197571000.00
OCUL cash_flow (annual, 2023-12-31) — Financing Cash Flow: 169828000.00
OCUL balance_sheet (annual, 2023-12-31) — Finished Goods: 991000.00
OCUL cash_flow (annual, 2023-12-31) — Free Cash Flow: -76321000.00
OCUL cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 5188000.00
OCUL cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 1000.00
OCUL income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -5188000.00
OCUL income_statement (annual, 2023-12-31) — General And Administrative Expense: 69661000.00
OCUL balance_sheet (annual, 2023-12-31) — Gross PPE: 38471000.00
OCUL income_statement (annual, 2023-12-31) — Gross Profit: 53162000.00
OCUL income_statement (annual, 2023-12-31) — Interest Expense: 11338000.00
OCUL income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 11338000.00
OCUL income_statement (annual, 2023-12-31) — Interest Income: 3983000.00
OCUL income_statement (annual, 2023-12-31) — Interest Income Non Operating: 3983000.00
OCUL cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 5464000.00
OCUL balance_sheet (annual, 2023-12-31) — Interest Payable: 11689000.00
OCUL balance_sheet (annual, 2023-12-31) — Inventory: 2305000.00
OCUL balance_sheet (annual, 2023-12-31) — Invested Capital: 166056000.00
OCUL cash_flow (annual, 2023-12-31) — Investing Cash Flow: -6087000.00
OCUL cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 118112000.00
OCUL cash_flow (annual, 2023-12-31) — Issuance Of Debt: 84474000.00
OCUL balance_sheet (annual, 2023-12-31) — Leases: 14699000.00
OCUL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 6878000.00
OCUL balance_sheet (annual, 2023-12-31) — Long Term Debt: 74925000.00
OCUL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 81803000.00
OCUL cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 82474000.00
OCUL cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -26125000.00
OCUL balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1504000.00
OCUL cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 118112000.00
OCUL income_statement (annual, 2023-12-31) — Net Income: -80736000.00
OCUL income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -80736000.00
OCUL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -80736000.00
OCUL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -80736000.00
OCUL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -80736000.00
OCUL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -80736000.00
OCUL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -80736000.00
OCUL income_statement (annual, 2023-12-31) — Net Interest Income: -7355000.00
OCUL cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 56349000.00
OCUL cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 56349000.00
OCUL income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -7355000.00
OCUL cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -5184000.00
OCUL balance_sheet (annual, 2023-12-31) — Net PPE: 18211000.00
OCUL cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -6087000.00
OCUL cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 0.00
OCUL balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 91131000.00
OCUL balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 14135000.00
OCUL balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 14135000.00
OCUL income_statement (annual, 2023-12-31) — Normalized EBITDA: -75417000.00
OCUL income_statement (annual, 2023-12-31) — Normalized Income: -89738000.00
OCUL cash_flow (annual, 2023-12-31) — Operating Cash Flow: -70234000.00
OCUL cash_flow (annual, 2023-12-31) — Operating Gains Losses: -9001000.00
OCUL income_statement (annual, 2023-12-31) — Operating Income: -82382000.00
OCUL income_statement (annual, 2023-12-31) — Operating Revenue: 58443000.00
OCUL balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 114963193.00
OCUL balance_sheet (annual, 2023-12-31) — Other Current Assets: 7794000.00
OCUL income_statement (annual, 2023-12-31) — Other Gand A: 20871000.00
OCUL income_statement (annual, 2023-12-31) — Other Income Expense: 9001000.00
OCUL cash_flow (annual, 2023-12-31) — Other Non Cash Items: 6106000.00
OCUL balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1614000.00
OCUL balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 108000.00
OCUL income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -1000.00
OCUL balance_sheet (annual, 2023-12-31) — Other Properties: 21987000.00
OCUL income_statement (annual, 2023-12-31) — Other Special Charges: -14190000.00
OCUL balance_sheet (annual, 2023-12-31) — Payables: 4389000.00
OCUL balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 33055000.00
OCUL balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
OCUL income_statement (annual, 2023-12-31) — Pretax Income: -80736000.00
OCUL cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 551000.00
OCUL balance_sheet (annual, 2023-12-31) — Properties: 0.00
OCUL cash_flow (annual, 2023-12-31) — Purchase Of PPE: -6087000.00
OCUL balance_sheet (annual, 2023-12-31) — Raw Materials: 302000.00
OCUL balance_sheet (annual, 2023-12-31) — Receivables: 26179000.00
OCUL income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 5281000.00
OCUL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2983000.00
OCUL cash_flow (annual, 2023-12-31) — Repayment Of Debt: -28125000.00
OCUL income_statement (annual, 2023-12-31) — Research And Development: 61055000.00
OCUL balance_sheet (annual, 2023-12-31) — Restricted Cash: 150000.00
OCUL balance_sheet (annual, 2023-12-31) — Retained Earnings: -697578000.00
OCUL income_statement (annual, 2023-12-31) — Salaries And Wages: 48790000.00
OCUL cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
OCUL income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 4828000.00
OCUL income_statement (annual, 2023-12-31) — Selling General And Administration: 74489000.00
OCUL balance_sheet (annual, 2023-12-31) — Share Issued: 114963193.00
OCUL cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 2000000.00
OCUL cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -2000000.00
OCUL income_statement (annual, 2023-12-31) — Special Income Charges: 14190000.00
OCUL cash_flow (annual, 2023-12-31) — Stock Based Compensation: 17825000.00
OCUL balance_sheet (annual, 2023-12-31) — Stockholders Equity: 91131000.00
OCUL balance_sheet (annual, 2023-12-31) — Tangible Book Value: 91131000.00
OCUL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
OCUL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
OCUL balance_sheet (annual, 2023-12-31) — Total Assets: 252060000.00
OCUL balance_sheet (annual, 2023-12-31) — Total Capitalization: 166056000.00
OCUL balance_sheet (annual, 2023-12-31) — Total Debt: 83389000.00
OCUL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 91131000.00
OCUL income_statement (annual, 2023-12-31) — Total Expenses: 140825000.00
OCUL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 160929000.00
OCUL balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 19825000.00
OCUL balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 126033000.00
OCUL income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -82382000.00
OCUL income_statement (annual, 2023-12-31) — Total Unusual Items: 9002000.00
OCUL income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 9002000.00
OCUL balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
OCUL balance_sheet (annual, 2023-12-31) — Work In Process: 1012000.00
OCUL balance_sheet (annual, 2023-12-31) — Working Capital: 197339000.00
OCUL cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
OCUL cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
OCUL cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 0.00
OCUL cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
OCUL balance_sheet (quarterly, 2024-09-30) — Restricted Cash: 0.00
OCUL cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 0.00
OCUL cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: 0.00
OCUL income_statement (annual, 2024-12-31) — +Operating Expense: 229878000.00
OCUL income_statement (annual, 2024-12-31) — +Total Revenue: 63723000.00
OCUL balance_sheet (annual, 2024-12-31) — Accounts Payable: 4176000.00
OCUL balance_sheet (annual, 2024-12-31) — Accounts Receivable: 32388000.00
OCUL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -23632000.00
OCUL balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -23632000.00
OCUL balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1206412000.00
OCUL income_statement (annual, 2024-12-31) — Basic Average Shares: 158265162.00
OCUL income_statement (annual, 2024-12-31) — Basic EPS: -1.22
OCUL cash_flow (annual, 2024-12-31) — Beginning Cash Position: 197571000.00
OCUL cash_flow (annual, 2024-12-31) — Capital Expenditure: -1288000.00
OCUL balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 7278000.00
OCUL balance_sheet (annual, 2024-12-31) — Capital Stock: 16000.00
OCUL balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 392102000.00
OCUL balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 392102000.00
OCUL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 332110000.00
OCUL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1288000.00
OCUL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -134677000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Account Payable: -318000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 3638000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Inventory: -735000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 505000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -1186000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -262000.00
OCUL cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -62000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Payable: -318000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 3320000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -5663000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Receivables: -6209000.00
OCUL cash_flow (annual, 2024-12-31) — Change In Working Capital: -10230000.00
OCUL cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -6209000.00
OCUL cash_flow (annual, 2024-12-31) — Changes In Cash: 196145000.00
OCUL balance_sheet (annual, 2024-12-31) — Common Stock: 16000.00
OCUL balance_sheet (annual, 2024-12-31) — Common Stock Equity: 315344000.00
OCUL cash_flow (annual, 2024-12-31) — Common Stock Issuance: 317369000.00
OCUL cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 524000.00
OCUL balance_sheet (annual, 2024-12-31) — Construction In Progress: 119000.00
OCUL balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 119000.00
OCUL income_statement (annual, 2024-12-31) — Cost Of Revenue: 5626000.00
OCUL balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 35117000.00
OCUL balance_sheet (annual, 2024-12-31) — Current Assets: 440987000.00
OCUL balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1933000.00
OCUL balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1933000.00
OCUL balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 128000.00
OCUL balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 128000.00
OCUL balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 128000.00
OCUL balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 128000.00
OCUL balance_sheet (annual, 2024-12-31) — Current Liabilities: 41354000.00
OCUL cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 3786000.00
OCUL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 3786000.00
OCUL balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 13246000.00
OCUL income_statement (annual, 2024-12-31) — Diluted Average Shares: 158265162.00
OCUL income_statement (annual, 2024-12-31) — Diluted EPS: -1.22
OCUL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -193506000.00
OCUL income_statement (annual, 2024-12-31) — EBIT: -179929000.00
OCUL income_statement (annual, 2024-12-31) — EBITDA: -176143000.00
OCUL cash_flow (annual, 2024-12-31) — End Cash Position: 393716000.00
OCUL cash_flow (annual, 2024-12-31) — Financing Cash Flow: 332110000.00
OCUL balance_sheet (annual, 2024-12-31) — Finished Goods: 1337000.00
OCUL cash_flow (annual, 2024-12-31) — Free Cash Flow: -135965000.00
OCUL cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 480000.00
OCUL cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
OCUL income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -480000.00
OCUL income_statement (annual, 2024-12-31) — General And Administrative Expense: 97128000.00
OCUL balance_sheet (annual, 2024-12-31) — Gross PPE: 38966000.00
OCUL income_statement (annual, 2024-12-31) — Gross Profit: 58097000.00
OCUL income_statement (annual, 2024-12-31) — Interest Expense: 13577000.00
OCUL income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 13577000.00
OCUL income_statement (annual, 2024-12-31) — Interest Income: 20282000.00
OCUL income_statement (annual, 2024-12-31) — Interest Income Non Operating: 20282000.00
OCUL cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 21533000.00
OCUL balance_sheet (annual, 2024-12-31) — Interest Payable: 592000.00
OCUL balance_sheet (annual, 2024-12-31) — Inventory: 3040000.00
OCUL balance_sheet (annual, 2024-12-31) — Invested Capital: 383849000.00
OCUL cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1288000.00
OCUL cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 317369000.00
OCUL cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 524000.00
OCUL cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
OCUL cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
OCUL balance_sheet (annual, 2024-12-31) — Leases: 14528000.00
OCUL balance_sheet (quarterly, 2024-12-31) — Leases: 14528000.00
OCUL balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 5345000.00
OCUL balance_sheet (annual, 2024-12-31) — Long Term Debt: 68505000.00
OCUL balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 73850000.00
OCUL cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
OCUL cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
OCUL cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
OCUL cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
OCUL balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1592000.00
OCUL balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1592000.00
OCUL cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 317369000.00
OCUL cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 524000.00
OCUL income_statement (annual, 2024-12-31) — Net Income: -193506000.00
OCUL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -193506000.00
OCUL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -193506000.00
OCUL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -193506000.00
OCUL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -193506000.00
OCUL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -193506000.00
OCUL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -193506000.00
OCUL income_statement (annual, 2024-12-31) — Net Interest Income: 6705000.00
OCUL cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
OCUL cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
OCUL cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
OCUL cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
OCUL income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 6705000.00
OCUL balance_sheet (annual, 2024-12-31) — Net PPE: 15334000.00
OCUL cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1288000.00
OCUL cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
OCUL cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
OCUL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 315344000.00
OCUL balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 14000000.00
OCUL balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 14000000.00
OCUL income_statement (annual, 2024-12-31) — Normalized EBITDA: -147713000.00
OCUL income_statement (annual, 2024-12-31) — Normalized Income: -165076000.00
OCUL cash_flow (annual, 2024-12-31) — Operating Cash Flow: -134677000.00
OCUL cash_flow (annual, 2024-12-31) — Operating Gains Losses: 28430000.00
OCUL income_statement (annual, 2024-12-31) — Operating Income: -171781000.00
OCUL income_statement (annual, 2024-12-31) — Operating Revenue: 63723000.00
OCUL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 157749490.00
OCUL balance_sheet (annual, 2024-12-31) — Other Current Assets: 13457000.00
OCUL income_statement (annual, 2024-12-31) — Other Gand A: 29279000.00
OCUL income_statement (annual, 2024-12-31) — Other Income Expense: -28430000.00
OCUL cash_flow (annual, 2024-12-31) — Other Non Cash Items: 3734000.00
OCUL balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1614000.00
OCUL balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 141000.00
OCUL balance_sheet (annual, 2024-12-31) — Other Properties: 22727000.00
OCUL income_statement (annual, 2024-12-31) — Other Special Charges: 27950000.00
OCUL income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
OCUL balance_sheet (annual, 2024-12-31) — Payables: 4176000.00
OCUL balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 39293000.00
OCUL balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
OCUL income_statement (annual, 2024-12-31) — Pretax Income: -193506000.00
OCUL cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 14741000.00
OCUL balance_sheet (annual, 2024-12-31) — Properties: 0.00
OCUL balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
OCUL cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1288000.00
OCUL balance_sheet (annual, 2024-12-31) — Raw Materials: 214000.00
OCUL balance_sheet (annual, 2024-12-31) — Receivables: 32388000.00
OCUL income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 5626000.00
OCUL income_statement (annual, 2024-12-31) — Reconciled Depreciation: 3786000.00
OCUL cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
OCUL cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
OCUL income_statement (annual, 2024-12-31) — Research And Development: 127635000.00
OCUL balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
OCUL balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
OCUL balance_sheet (annual, 2024-12-31) — Retained Earnings: -891084000.00
OCUL income_statement (annual, 2024-12-31) — Salaries And Wages: 67849000.00
OCUL income_statement (quarterly, 2024-12-31) — Salaries And Wages: 15899000.00
OCUL cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
OCUL income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 5115000.00
OCUL income_statement (annual, 2024-12-31) — Selling General And Administration: 102243000.00
OCUL balance_sheet (annual, 2024-12-31) — Share Issued: 157749490.00
OCUL cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
OCUL cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 0.00
OCUL cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
OCUL cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
OCUL income_statement (annual, 2024-12-31) — Special Income Charges: -27950000.00
OCUL income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
OCUL cash_flow (annual, 2024-12-31) — Stock Based Compensation: 33109000.00
OCUL balance_sheet (annual, 2024-12-31) — Stockholders Equity: 315344000.00
OCUL balance_sheet (annual, 2024-12-31) — Tangible Book Value: 315344000.00
OCUL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
OCUL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
OCUL balance_sheet (annual, 2024-12-31) — Total Assets: 457935000.00
OCUL balance_sheet (annual, 2024-12-31) — Total Capitalization: 383849000.00
OCUL balance_sheet (annual, 2024-12-31) — Total Debt: 75783000.00
OCUL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 315344000.00
OCUL income_statement (annual, 2024-12-31) — Total Expenses: 235504000.00
OCUL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 142591000.00
OCUL balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 16948000.00
OCUL balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 101237000.00
OCUL income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -171781000.00
OCUL income_statement (annual, 2024-12-31) — Total Unusual Items: -28430000.00
OCUL income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -28430000.00
OCUL balance_sheet (annual, 2024-12-31) — Work In Process: 1489000.00
OCUL balance_sheet (annual, 2024-12-31) — Working Capital: 399633000.00
OCUL income_statement (quarterly, 2025-03-31) — +Operating Expense: 73353000.00
OCUL income_statement (quarterly, 2025-03-31) — +Total Revenue: 10698000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4626000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 25221000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1221051000.00
OCUL income_statement (quarterly, 2025-03-31) — Basic Average Shares: 169396989.00
OCUL income_statement (quarterly, 2025-03-31) — Basic EPS: -0.38
OCUL cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 393716000.00
OCUL cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1933000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 7022000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Capital Stock: 16000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 349681000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 349681000.00
OCUL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 4183000.00
OCUL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1933000.00
OCUL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -44671000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 7000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -5145000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Inventory: -229000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 117000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -256000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -64000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Payable: 7000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -5138000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 3934000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Receivables: 7167000.00
OCUL cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 5531000.00
OCUL cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 7167000.00
OCUL cash_flow (quarterly, 2025-03-31) — Changes In Cash: -42421000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Common Stock: 16000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 265930000.00
OCUL cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
OCUL income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1262000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 31080000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Current Assets: 387694000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 2156000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2156000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 64000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 64000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 37926000.00
OCUL cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 981000.00
OCUL cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 981000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 13852000.00
OCUL income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 169396989.00
OCUL income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.38
OCUL income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -64053000.00
OCUL income_statement (quarterly, 2025-03-31) — EBIT: -61069000.00
OCUL income_statement (quarterly, 2025-03-31) — EBITDA: -60088000.00
OCUL cash_flow (quarterly, 2025-03-31) — End Cash Position: 351295000.00
OCUL cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 4183000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Finished Goods: 1277000.00
OCUL cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -46604000.00
OCUL cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 978000.00
OCUL cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
OCUL income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -978000.00
OCUL income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 16348000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Gross PPE: 16612000.00
OCUL income_statement (quarterly, 2025-03-31) — Gross Profit: 9436000.00
OCUL income_statement (quarterly, 2025-03-31) — Interest Expense: 2984000.00
OCUL income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2984000.00
OCUL income_statement (quarterly, 2025-03-31) — Interest Income: 3826000.00
OCUL income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3826000.00
OCUL cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 2140000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Interest Payable: 736000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Inventory: 3269000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Invested Capital: 335132000.00
OCUL cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1933000.00
OCUL cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
OCUL balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 4866000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 69202000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 74068000.00
OCUL cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
OCUL income_statement (quarterly, 2025-03-31) — Net Income: -64053000.00
OCUL income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -64053000.00
OCUL income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -64053000.00
OCUL income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -64053000.00
OCUL income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -64053000.00
OCUL cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -64053000.00
OCUL income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -64053000.00
OCUL income_statement (quarterly, 2025-03-31) — Net Interest Income: 842000.00
OCUL income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 842000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Net PPE: 16612000.00
OCUL cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1933000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 265930000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 14000000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 14000000.00
OCUL income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -59110000.00
OCUL income_statement (quarterly, 2025-03-31) — Normalized Income: -63075000.00
OCUL cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -44671000.00
OCUL cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 978000.00
OCUL income_statement (quarterly, 2025-03-31) — Operating Income: -63917000.00
OCUL income_statement (quarterly, 2025-03-31) — Operating Revenue: 10698000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 159262024.00
OCUL balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 9523000.00
OCUL income_statement (quarterly, 2025-03-31) — Other Gand A: 16348000.00
OCUL income_statement (quarterly, 2025-03-31) — Other Income Expense: -978000.00
OCUL cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1436000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1614000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 144000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Other Properties: 16612000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Payables: 4626000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 35706000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
OCUL income_statement (quarterly, 2025-03-31) — Pretax Income: -64053000.00
OCUL cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 4183000.00
OCUL cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1933000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Raw Materials: 187000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Receivables: 25221000.00
OCUL income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1262000.00
OCUL income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 981000.00
OCUL income_statement (quarterly, 2025-03-31) — Research And Development: 42857000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -955137000.00
OCUL income_statement (quarterly, 2025-03-31) — Salaries And Wages: 19741000.00
OCUL income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 14148000.00
OCUL income_statement (quarterly, 2025-03-31) — Selling General And Administration: 30496000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Share Issued: 159262024.00
OCUL income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
OCUL cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 10456000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 265930000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 265930000.00
OCUL income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
OCUL income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
OCUL balance_sheet (quarterly, 2025-03-31) — Total Assets: 405920000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 335132000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Total Debt: 76224000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 265930000.00
OCUL income_statement (quarterly, 2025-03-31) — Total Expenses: 74615000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 139990000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 18226000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 102064000.00
OCUL income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -63917000.00
OCUL income_statement (quarterly, 2025-03-31) — Total Unusual Items: -978000.00
OCUL income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -978000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Work In Process: 1805000.00
OCUL balance_sheet (quarterly, 2025-03-31) — Working Capital: 349768000.00
OCUL income_statement (quarterly, 2025-06-30) — +Operating Expense: 79156000.00
OCUL income_statement (quarterly, 2025-06-30) — +Total Revenue: 13459000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5889000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 30412000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1328850000.00
OCUL income_statement (quarterly, 2025-06-30) — Basic Average Shares: 172594662.00
OCUL income_statement (quarterly, 2025-06-30) — Basic EPS: -0.39
OCUL cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 351295000.00
OCUL cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1245000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 7033000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 17000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 391134000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 391134000.00
OCUL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 97806000.00
OCUL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1115000.00
OCUL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -55238000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1731000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 2841000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Inventory: 230000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -55000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 11000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -64000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Payable: 1731000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 4572000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 1049000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Receivables: -5191000.00
OCUL cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 552000.00
OCUL cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -5191000.00
OCUL cash_flow (quarterly, 2025-06-30) — Changes In Cash: 41453000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Common Stock: 17000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 305916000.00
OCUL cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 94738000.00
OCUL income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1944000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 34417000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Current Assets: 433375000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 2625000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2625000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 0.00
OCUL balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 0.00
OCUL balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 42931000.00
OCUL cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1026000.00
OCUL cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1026000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 14024000.00
OCUL income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 172594662.00
OCUL income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.39
OCUL income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -67814000.00
OCUL income_statement (quarterly, 2025-06-30) — EBIT: -64798000.00
OCUL income_statement (quarterly, 2025-06-30) — EBITDA: -63772000.00
OCUL cash_flow (quarterly, 2025-06-30) — End Cash Position: 392748000.00
OCUL cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 97806000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Finished Goods: 1084000.00
OCUL cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -56483000.00
OCUL cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 641000.00
OCUL cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -29000.00
OCUL income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 29000.00
OCUL income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -641000.00
OCUL income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 26556000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Gross PPE: 16344000.00
OCUL income_statement (quarterly, 2025-06-30) — Gross Profit: 11515000.00
OCUL income_statement (quarterly, 2025-06-30) — Interest Expense: 3016000.00
OCUL income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 3016000.00
OCUL income_statement (quarterly, 2025-06-30) — Interest Income: 3455000.00
OCUL income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 3455000.00
OCUL cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 2308000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Interest Payable: 736000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Inventory: 3039000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 375822000.00
OCUL cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1115000.00
OCUL cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 94738000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 4408000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 69906000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 74314000.00
OCUL cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 94738000.00
OCUL income_statement (quarterly, 2025-06-30) — Net Income: -67814000.00
OCUL income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -67814000.00
OCUL income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -67814000.00
OCUL income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -67814000.00
OCUL income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -67814000.00
OCUL cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -67814000.00
OCUL income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -67814000.00
OCUL income_statement (quarterly, 2025-06-30) — Net Interest Income: 439000.00
OCUL income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 439000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Net PPE: 16344000.00
OCUL cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1115000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 305916000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 14000000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 14000000.00
OCUL income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -63160000.00
OCUL income_statement (quarterly, 2025-06-30) — Normalized Income: -67202000.00
OCUL cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -55238000.00
OCUL cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 612000.00
OCUL income_statement (quarterly, 2025-06-30) — Operating Income: -67641000.00
OCUL income_statement (quarterly, 2025-06-30) — Operating Revenue: 13459000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 172925389.00
OCUL balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 8790000.00
OCUL income_statement (quarterly, 2025-06-30) — Other Gand A: 9126000.00
OCUL income_statement (quarterly, 2025-06-30) — Other Income Expense: -612000.00
OCUL cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 708000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1614000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 148000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Other Properties: 16344000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Payables: 5889000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 40306000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
OCUL income_statement (quarterly, 2025-06-30) — Pretax Income: -67814000.00
OCUL cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 3068000.00
OCUL cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1245000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Raw Materials: 219000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Receivables: 30412000.00
OCUL income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1944000.00
OCUL income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1026000.00
OCUL income_statement (quarterly, 2025-06-30) — Research And Development: 51081000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1022951000.00
OCUL income_statement (quarterly, 2025-06-30) — Salaries And Wages: 17430000.00
OCUL income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1519000.00
OCUL income_statement (quarterly, 2025-06-30) — Selling General And Administration: 28075000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Share Issued: 172925389.00
OCUL income_statement (quarterly, 2025-06-30) — Special Income Charges: 29000.00
OCUL cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 9678000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 305916000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 305916000.00
OCUL income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
OCUL income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
OCUL balance_sheet (quarterly, 2025-06-30) — Total Assets: 451333000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 375822000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Total Debt: 76939000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 305916000.00
OCUL income_statement (quarterly, 2025-06-30) — Total Expenses: 81100000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 145417000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 17958000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 102486000.00
OCUL income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -67641000.00
OCUL income_statement (quarterly, 2025-06-30) — Total Unusual Items: -612000.00
OCUL income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -612000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Work In Process: 1736000.00
OCUL balance_sheet (quarterly, 2025-06-30) — Working Capital: 390444000.00
OCUL income_statement (quarterly, 2025-09-30) — +Operating Expense: 81468000.00
OCUL income_statement (quarterly, 2025-09-30) — +Total Revenue: 14544000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 6260000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 30768000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1350580000.00
OCUL income_statement (quarterly, 2025-09-30) — Basic Average Shares: 183919808.00
OCUL income_statement (quarterly, 2025-09-30) — Basic EPS: -0.38
OCUL cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 392748000.00
OCUL cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -5993000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 6391000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Capital Stock: 18000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 344772000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 344772000.00
OCUL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 10356000.00
OCUL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5993000.00
OCUL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -50725000.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1272000.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 5376000.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Inventory: -449000.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 549000.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -642000.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 0.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Payable: -1272000.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 4104000.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 522000.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Receivables: -356000.00
OCUL cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 3728000.00
OCUL cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -356000.00
OCUL cash_flow (quarterly, 2025-09-30) — Changes In Cash: -46362000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Common Stock: 18000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 258229000.00
OCUL cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
OCUL income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1774000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 40272000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Current Assets: 386980000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2762000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2762000.00
OCUL balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 0.00